Stanford University
Showing 6,911-6,920 of 7,777 Results
-
Daniel SW Ting
Adjunct Clinical Associate Professor, Ophthalmology
BioAssoc Prof Daniel Ting is a senior consultant vitreo-retinal surgeon working in the Singapore National Eye Center (SNEC), an Associate Professor with Duke-NUS Medical School and an Adjunct Clinical Associate Professor and an Innovation Mentor at Stanford University. He is also the Director of Singapore Health Service (SingHealth) AI Office, SNEC Chief Data and Digital Officer, and the Head of AI and Digital Innovation in Singapore Eye Research Institute (SERI). In 2017, Dr Ting was US-ASEAN Fulbright Scholar visiting the Johns Hopkins University Fulbright Scholar to share his expertise in AI and big data in medicine. In addition to that, his research focus span across not only on the technical aspect on machine learning, deep learning, large language models, explainable AI, privacy preserving technologies, but also safe, responsible and ethical clinical AI applications. He is also involved in several international consensus reporting guidelines such as STARD-AI, QUADAS-AI and DECIDE-AI.
To date, Daniel has published >250 publications on peer reviewed, book chapters, educational articles and conference abstracts. Of those, 45 were published in high impact journals (IF >10) such as JAMA, NEJM, Lancet, Nature Medicine, Nature Biomedical Engineering, Lancet Digital Health, Progress in Retinal and Eye Research, Diabetes Care, Nature Digital Medicine, Ophthalmology and etc. As of Aug 2024 (Google Scholar), his current H index: 61, i-10 index: 172 with total citations of >20,000. Dr Ting has received a total of 100M research grants, in which 20 M as a principal investigator, and 80M as co-investigators on AI and digital innovation related projects in health.
Dr Ting serves in several leadership positions at the different AI and eye societies, including the American Academy of Ophthalmology AI and Retina Ophthalmology Technology Assessment committees, and he also chairs the AI and Digital Innovation Standing Committee for the Asia-Pacific Academy of Ophthalmology and Asia-Pacific Vitreo-Retinal Society. He also serves in numerous advisory and editorial boards in the top-tiered digital and medical journals, including Lancet Digital Health, Frontiers in Medicine, Frontiers in Digital Health and Asia-Pacific Journal of Ophthalmology; Section Editor in British Journal of Ophthalmology and Editorial Board Member in Ophthalmology, Ophthalmology Retina, Ophthalmology Science, British Journal of Ophthalmology, Asia-Pacific Journal of Ophthalmology and Retina.
For the accomplishment, Dr Ting was recognized by many top-tiered international AI and ophthalmology societies in winning many prestigious scientific awards, including Tatler Asia Gen T Award (2021), Singapore National Clinician Scientist Award (2021), Asia-Pacific Academy Ophthalmology (APAO) Nakajima Award (2021), Asia-Pacific Vitreo-Retinal Society (APVRS) Ian Constable Award (2021), MICCAI OMIA Prestigious Achievement Award (2020), ARVO Bert Glaser Award for Innovative Research in Retina (2020), USA Macula Society Evangelos Gragoudas Award (2019), APAO Young Ophthalmologist’s Award (2018) and APTOS Young Innovator Award (2017).
In 2022, 2023 and 2024, he is included in the World’s Top 100 Ophthalmology Power list by the Ophthalmologists; and the World’s Top 2% Scientists by the Stanford University world ranking. In 2021, 2022 and 2023, he was consistently ranked top 3 in the deep learning domain over the past decades (2010 – 2023) by the ExpertScape. In 2024, he won the Singapore National Academy of Medicine Young Scientist Award, and also ranked the Top 100 AI Thought Leaders Worldwide with Fei Fei Li, Yan LeCun, Jensen Huang and many others by H20.ai. -
Jamie L. Tingey, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
Current Research and Scholarly InterestsDr. Tingey’s research broadly focuses on factors that promote positive outcomes in patients with complex and/or chronic conditions. She is committed to research that focuses on outcomes that are valued by patients and healthcare stakeholders.
Some of her research interests include self-management interventions in chronic conditions (e.g., multiple sclerosis, stroke, spinal cord injury, traumatic brain injury) and adapting evidence-based treatments to provide equitable care to individuals with chronic conditions and disabilities. She is also passionate about integrating psychology services into critical care settings to improve health outcomes among ICU survivors. -
Julie Tinklenberg
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Vaden Health Center
BioDr. Julie Tinklenberg specializes in the treatment of mental illness in the university setting. She has worked in college mental health for over 15 years. Dr.Tinklenberg has a special interest in anxiety disorders, parenting issues, mood disorders and interpersonal/relationship problems.
-
Jyothi Tirumalasetty, MD, FAAAAI, FACAAI
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsReducing healthcare-related carbon emissions with a focus on inhalers.
Health disparities in food allergy.
Climate change and asthma. -
Rebecca Lauren Tisdale
Assistant Professor of Medicine (PCPH)
BioBecca Tisdale, MD, MPA is an internist, obesity medicine specialist, and health services researcher with interests in cardiovascular disease, global health, and health systems. As a VA Health Services Research & Development fellow (2020-2023) and Investigator in the VA Center for Innovation to Implementation (Ci2i) and Stanford Cardiovascular Outcomes, Policy, & Implementation Research Group (COPIR), her work has focused on value, access, and equity in cardiovascular disease care and the role of virtual care in achieving these goals.
Previously, she received a BA with distinction in Human Biology from Stanford in 2009, followed by a master of public administration (MPA) joint degree from Sciences Po, Paris and the London School of Economics. She then matriculated at Columbia University College of Physicians and Surgeons for medical school, where she was active in global health activities, researching multidisciplinary teams in HIV care in Ethiopia and serving on the board of the student international health organization. As a global health track resident at Stanford, Becca spent time working in Rwanda through the Johnson and Johnson program and participated in the inaugural Women Leaders in Global Health conferences at Stanford and in London. In 2019-2020, she comprised one third of Stanford’s first all-woman internal medicine chief resident cohort. Outside of work, she enjoys all things French as well as running, both in races and after her young children. -
Christina (Christy) Tise, MD, PhD
Assistant Professor of Pediatrics (Genetics) and, by courtesy, of Obstetrics & Gynecology (Reproductive Endocrinology and Infertility)
BioDr. Christina (Christy) Tise is a physician scientist and Assistant Professor in the Division of Medical Genetics at Stanford with subspecialty training in Clinical Biochemical Genetics. Dr. Tise has developed multiple research projects focused on the clinical impact of biochemical genetic conditions in pregnancy and newborn health, including a project focused on unforeseen diagnoses in individuals initially identified through state newborn screening which has resulted in a number of publications.
Dr. Tise also researches the genetic etiologies of recurrent pregnancy loss and the impact of inherited metabolic conditions on human reproduction. She is involved in several research initiatives including contributing to the development of TRIOS, a multi-site, NIH-funded research study to evaluate the genetic causes of recurrent pregnancy loss. In serving as the primary research mentor for a recent Masters of Genetic Counseling graduate, Dr. Tise’s research on carrier and newborn screening has highlighted areas of ancestry-related healthcare inequities specific to the field of Medical Genetics.
Dr. Tise’s primary academic and advocacy interests are embodied in this work, specifically the overlap between biochemical and molecular analysis, and the clinical utility of innovative technologies for diagnosis and treatment of genetic disease. This is an unbelievably thrilling time for the field of Medical Genetics, as it promises immense progress and opportunity for all fields of medicine, and Dr. Tise is determined, honored, and incredibly excited to be a part of it!
Research interests: newborn screening, carrier screening, prenatal screening, genetics of recurrent pregnancy loss, biochemical genetics, novel gene discovery, variant interpretation, founder populations, diagnostic genetic testing, bioethics, GWAS/ExWAS
